Transcriptional changes during hepatic ischemia-reperfusion in the rat.
There are few effective targeted strategies to reduce hepatic ischemia-reperfusion (IR) injury, a contributor to poor outcomes in liver transplantation recipients. It has been proposed that IR injury is driven by the generation of reactive oxygen species (ROS). However, recent studies implicate othe...
Guardado en:
Autores principales: | Valerie Zabala, Joan M Boylan, Paul Thevenot, Anderson Frank, Dewahar Senthoor, Varun Iyengar, Hannah Kim, Ari Cohen, Philip A Gruppuso, Jennifer A Sanders |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/12b5b00b6c6e468d98366405ff82160d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Antioxidant Transcription Factor Nrf2 in Cardiac Ischemia–Reperfusion Injury
por: Ana Mata, et al.
Publicado: (2021) -
Senolytic Therapy for Cerebral Ischemia-Reperfusion Injury
por: Songhyun Lim, et al.
Publicado: (2021) -
Effect of NAD+ boosting on kidney ischemia-reperfusion injury.
por: Marya Morevati, et al.
Publicado: (2021) -
Cardioprotective effects of empagliflozin after ischemia and reperfusion in rats
por: Jacob Marthinsen Seefeldt, et al.
Publicado: (2021) -
Macrophage Membrane-Coated Nanoparticles Alleviate Hepatic Ischemia-Reperfusion Injury Caused by Orthotopic Liver Transplantation by Neutralizing Endotoxin
por: Ou Z, et al.
Publicado: (2020)